Galp did something rare in July: it raised its full-year EBITDA guidance by roughly 50%, from above €2.6bn to around €4bn, lifted operating cash flow guidance to ~€3bn and bumped the dividend 10% to €0.70. The market's answer was to sell the stock from 20.96 to 19.38 in two sessions. Both reactions make sense. The raise is real but macro-made; refining margins and price marks did most of it, and it landed next to a revenue miss and a slight EBITDA shortfall in the quarter itself. Meanwhile the Namibia catalyst that carried the stock for a year (the Mopane stake sale to TotalEnergies) closed in late July: consumed. What remains is a 5.3x EV/EBITDA cash machine with a ~3.5% forward yield, an active €250M buyback, modest net debt, and a beta near zero (-0.08) — genuine decorrelation from equity indices, though that is a property of the recent regime, not a hedge to bank on. That mix is worth owning at the EMA20 zone around 19.45, where the risk/reward reads 2.5:1. It is not worth chasing under the 20-21 supply zone that just rejected the print.
Galp is Portugal's integrated energy company: upstream production (Brazil pre-salt, now a reshaped Namibia position), refining and marketing in Iberia, and a growing renewables book. The July report guided full-year EBITDA to roughly €4bn against €3.31bn trailing, powered by refining margins. The Mopane transaction with TotalEnergies — a non-cash asset swap that closed around July 23 — traded a concentrated exploration stake for positions in neighbouring blocks, de-risking the story at the cost of its lottery ticket.
| Metric | Value | Signal |
|---|---|---|
| Revenue (TTM) | €21.5B | Scale |
| EBITDA (TTM) | €3.31B | Guided to ~€4B FY26 |
| EV / EBITDA | 5.28x | Cheap |
| Net Debt | ~€2.27B | Light |
| Forward PE | 11.0x | Sector-typical |
| PEG | 0.95 | GARP |
| Dividend Yield | 3.34% | +10% to €0.70 |
| Analyst Mean Target | €22.26 | = 52w high |
| Quarter | EPS Actual | EPS Est. | Surprise |
|---|---|---|---|
| Q3 2025 (cal.) | €0.56 | €0.52 | +7.6% |
| Q4 2025 (cal.) | €0.24 | €0.19 | +30% |
| Q1 2026 (cal.) | €0.37 | €0.37 | +0.4% |
| Q2 2026 (cal.) | €0.72 | €0.65 | +11% |
Five straight bottom-line beats (Q2 2025 verified separately: €0.24 vs €0.16). The honest asterisk on the latest one: revenue missed widely, EBITDA came in a touch light (€1.27bn vs €1.28bn consensus), and tax effects helped the EPS line — which is exactly why the stock fell on a beat-and-raise day. Next report: 2026-10-26.
Shrinking: the completed prior buyback cancelled 16.5M shares on March 23 (capital reduced 753.5M → 737.0M); a €250M 2026 program has been running since March 2.
| RSI (14) | 53.2 |
| EMA 20 | €19.54 |
| EMA 50 | €19.32 |
| EMA 200 | €18.34 |
| MACD | 0.204 |
| Signal | 0.210 |
| ATR (14) | €0.56 |
The structure survived its own bad news: after the 20.96 post-guidance top on July 23, the flush stopped at 19.01 on July 27; above the EMA50, and the EMA20 was reclaimed within two sessions. Price now sits 1.3% above the EMA20 with the full stack rising underneath (19.54 > 19.32 > 18.34). Overhead, 20.00-21.00 is proven supply. The clean trade is the retest: 19.40-19.50 holding puts three rising averages under the position with the supply zone as the first target.
The risks are about quality-of-catalyst, not solvency: a macro-made guidance raise that crude can unmake, a consumed Namibia story, a narrow float, and a supply zone sitting right on top of the price.
A 5.3x EV/EBITDA cash machine with a freshly raised guide, a 3.4% growing dividend and a shrinking share count, priced for skepticism after a sell-the-news fade. The trade buys that skepticism at the EMA20 with a stop under the July floor, and sells back into the supply that created it.
A stock that falls on good news is showing you what was already priced in. No point arguing with that. Wait for the retest at your level and keep the stop under the July floor.
This analysis is provided for informational and educational purposes only. It does not constitute financial advice, investment recommendation, or solicitation to buy or sell any security.
Past performance is not indicative of future results. All investments involve risk, including the possible loss of principal. Always conduct your own research and consult a licensed financial advisor before making investment decisions.
Data sourced from real-time market data, Yahoo Finance, issuer and regulatory disclosures (Galp IR / CMVM), and public market data. Accuracy is not guaranteed.